Clinical trial
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an…
NCT00443443 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00443443 |
|---|---|
| Title | A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) |
| Official title | A Long-Term Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) |
| Acronym | SUNSTONE |
| Lead sponsor | Genentech, Inc., Industry |
| Collaborators | Biogen Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Enrollment | 1,026 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Mar 6, 2007 |
| Last update posted | Mar 30, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: